Debiopharm Group ^Investors

Debiopharm Group is a biopharmaceutical development specialist that focuses on in-licensing promising biologics and small molecule drug candidates. Their main goal is to develop these products for global registration and maximize their commercial potential for out-licensing to pharmaceutical partners for sales and marketing. With a strong emphasis on research and development, Debiopharm Group has achieved significant success in bringing innovative therapies to market.